McMaster University

McMaster University

The Pedi FETCh Research Trial

The Pedi FETCh Research Trial: Pediatric Fecal Transplant for Ulcerative Colitis (FETCh)

The Pedi FETCh Research Trial (Pediatric Fecal Transplant for Ulcerative Colitis) is the first pediatric fecal transplant study for inflammatory bowel disease in Canada, and will be the first randomized controlled trial of fecal transplant in pediatric inflammatory bowel disease in the world. The trial is being lead by Dr. Nikhil Pai, and supported by the Division of Pediatric Gastroenterology and Nutrition at McMaster Children’s Hospital. Study collaborators include Dr. Christine Lee (Division of Infectious Disease at St. Joseph's Hospital in Hamilton), and Paul Moayyedi (Division of Adult Gastroenterology at McMaster University), with support from the Farncombe Digestive Disease Research Institute at McMaster University.

Who is Eligible?

Patients between 6-17 years of age who have been diagnosed with ulcerative colitis or IBD-Unclassified may be eligible. Eligible patients must also:

  • have active disease (PUCAI Score >10)
  • have not experienced major changes to their treatment within the past 12 weeks (i.e. no new medications or dosage adjustments)

This trial is open for patients who are followed outside McMaster Children's Hospital. Please speak to your doctor and we can discuss how you or your child may be eligible for participation.

Children younger than six years of age and those who have started new medications during the study period may be excluded from the trial. Speak to your doctor to determine your eligibility and a study team member can contact you for further information.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0